UK markets closed

CVS Health Corporation (0HRS.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
84.72+0.35 (+0.41%)
At close: 2:36PM BST
Currency in USD

Valuation measures

Market cap (intra-day) 5109.61B
Enterprise value 3184.92B
Trailing P/E 15.09
Forward P/E 1N/A
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)0.41
Price/book (mrq)1.57
Enterprise value/revenue 30.69
Enterprise value/EBITDA 710.22

Trading information

Stock price history

Beta (5Y monthly) 0.82
52-week change 3N/A
S&P500 52-week change 343.61%
52-week high 384.72
52-week low 384.72
50-day moving average 3N/A
200-day moving average 3N/A

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 51.02B
Implied shares outstanding 6N/A
Float 1.31B
% held by insiders 10.18%
% held by institutions 178.77%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 32.00
Trailing annual dividend yield 32.37%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2020
Most-recent quarter (mrq)31 Mar 2021

Profitability

Profit margin 2.74%
Operating margin (ttm)5.04%

Management effectiveness

Return on assets (ttm)3.70%
Return on equity (ttm)10.85%

Income statement

Revenue (ttm)270.11B
Revenue per share (ttm)206.08
Quarterly revenue growth (yoy)3.30%
Gross profit (ttm)48.25B
EBITDA 18.1B
Net income avi to common (ttm)7.4B
Diluted EPS (ttm)5.61
Quarterly earnings growth (yoy)10.80%

Balance sheet

Total cash (mrq)8.79B
Total cash per share (mrq)6.68
Total debt (mrq)82.32B
Total debt/equity (mrq)115.67
Current ratio (mrq)0.93
Book value per share (mrq)53.96

Cash flow statement

Operating cash flow (ttm)15.45B
Levered free cash flow (ttm)12.33B